Ketamine produces a broad and measurable set of effects on the eyes, from visible changes like involuntary jerking movements and altered pupil responses to subtler shifts in how the brain processes visual information. These effects are dose-dependent and show up across multiple layers of the visual system, from the retina to the visual cortex. Because researchers also use ketamine as a pharmacological model for certain psychiatric conditions, the drug’s impact on eye movements has become one of the better-studied areas of oculomotor pharmacology.
How Ketamine Changes Saccadic Eye Movements
Saccades are the rapid, darting movements your eyes make as they jump from one point of focus to another. They are among the fastest movements the human body produces, and ketamine slows them down in several distinct ways. In studies using marmosets viewing natural images, ketamine reduced both the size and speed of saccades. The eyes covered less ground with each jump, and each jump took longer to complete. The total scanpath length, essentially how much visual territory the eyes explored, shrank under ketamine compared to a saline control. The number of saccades and fixations also trended downward, meaning the animals looked at fewer things overall.1PubMed Central. The effect of ketamine on eye movement characteristics during free-viewing of natural images in common marmosets
The picture gets more specific when you separate different types of saccades. At subanesthetic doses, ketamine strongly reduced what are called anticipatory saccades, the kind of preemptive eye movements your brain makes when it expects something to appear in a particular spot. But visually guided saccades, the straightforward reaction of looking at something that just appeared, stayed largely intact at the same dose.2Psychopharmacology. A subanesthetic dose of ketamine in the Rhesus monkey reduces the occurrence of anticipatory saccades This distinction matters because it suggests ketamine is not simply slowing down the eye muscles. It is interfering with the brain’s predictive machinery, the part that plans where to look next based on expectations rather than raw sensory input.
Reflexive saccade latency also increases under ketamine, meaning it takes longer for the eyes to snap toward a new stimulus even when one does appear.3Biological Psychiatry. Ketamine-induced distractibility: An oculomotor study in monkeys So the overall effect is a kind of visual sluggishness: fewer eye movements, smaller ones, slower ones, and less anticipation of where to look.
Smooth Pursuit Tracking Falls Apart
Smooth pursuit is the ability to keep your eyes locked on a moving target, like following a bird across the sky or watching a car pass. It requires a continuous feedback loop between the eyes and the brain, and ketamine disrupts it clearly. Under ketamine, the eyes cannot keep pace with a smoothly moving target. Instead, the brain compensates by inserting small corrective saccades, quick catch-up jumps to get back on track. Studies in both monkeys and humans have found that ketamine significantly increases the frequency of these catch-up saccades while reducing pursuit gain, a measure of how closely the eye’s speed matches the target’s speed.4National Science Review. Decoding effects of psychoactive drugs in a high-dimensional space of eye movements in monkeys
The disruption is not limited to catch-up saccades. Ketamine also increases the number of “leading” saccades, which are eye movements that jump ahead of the target rather than lagging behind it. This effect was particularly strong when targets moved at slower speeds, suggesting that the brain’s pursuit system loses calibration at lower demands, not just at high ones.5PubMed. Effects of ketamine on leading saccades during smooth-pursuit eye movements may implicate cerebellar dysfunction in schizophrenia
This smooth pursuit impairment has attracted attention from psychiatric researchers because similar tracking deficits show up consistently in people with schizophrenia. Ketamine’s effect on smooth pursuit performance closely mirrors the deviations found in schizophrenia patients, which supports the idea that glutamate dysfunction plays a role in those tracking problems. Brain imaging during ketamine-impaired smooth pursuit reveals altered activity in regions associated with oculomotor control, reinforcing the connection.6PubMed Central. Effects of ketamine on brain function during smooth pursuit eye movements
Nystagmus and Involuntary Eye Jerking
One of the most recognizable “ketamine eyes” effects is nystagmus, a rhythmic, involuntary oscillation of the eyes. The type most commonly associated with ketamine is gaze-evoked nystagmus, which appears when the eyes move to an extreme lateral or vertical position and then begin to drift and snap back repeatedly.3Biological Psychiatry. Ketamine-induced distractibility: An oculomotor study in monkeys In everyday terms, if someone under the influence of ketamine looks far to the left or right, their eyes may wobble rather than hold steady.
Horizontal gaze nystagmus (HGN) is also a prominent finding in field assessments of ketamine-impaired individuals. In a study of ketamine-only users compared to drug-free controls, HGN was among the most typical observable signs, alongside elevated pulse rate and difficulty with balance tests like walking in a straight line or standing on one leg.7PubMed. Roadside detection of impairment under the influence of ketamine–evaluation of ketamine impairment symptoms with reference to its concentration in oral fluid and urine This makes nystagmus one of the most practical visible markers that someone has used ketamine, which is why it plays a central role in forensic evaluations.
What Happens to the Pupils
Ketamine’s effect on the pupils is more nuanced than simple dilation or constriction. The main finding is that ketamine dampens the pupillary light reflex, the automatic narrowing of the pupil when a bright light hits the eye. During general anesthesia, ketamine combined with nitrous oxide depressed this reflex by roughly half.8PubMed. The effect of ketamine and nitrous oxide on the human pupillary light reflex during general anesthesia The mechanism likely involves NMDA receptor blockade within the neural circuits that control pupil size, since both ketamine and nitrous oxide are NMDA antagonists and both produced the same suppressive effect.
The dose relationship is fairly clear: as the amount of ketamine increases, both the pupillary light reflex and the pupillary dilation response become more blunted.9PubMed. Effects of Ketamine on Pupillary Reflex Dilation: A Case Report This means the pupil becomes less responsive in both directions. It does not constrict as much to light and does not dilate as much to darkness or pain. For clinicians monitoring patients during ketamine sedation, this sluggish pupil response can complicate the standard neurological checks that rely on brisk pupil reactivity as a sign of normal brain function.
Intraocular Pressure
Whether ketamine raises the pressure inside the eye has been a practical concern for decades, particularly in pediatric ophthalmology, where children often need sedation for eye pressure measurements. The evidence suggests the effect is small and dose-dependent. In children already anesthetized with halothane, a higher dose of ketamine (around 6 mg/kg) caused a small, brief increase in intraocular pressure at five to ten minutes, while a lower dose (around 3 mg/kg) did not change it at all.10PubMed. The effect of different doses of ketamine on intraocular pressure in anesthetized children
A separate comparison of ketamine versus the inhaled anesthetic sevoflurane found that intraocular pressure measured after ketamine sedation was more representative of the child’s actual awake pressure than measurements taken under sevoflurane. By eight minutes after ketamine administration, IOP was about 7% lower than the initial reading, whereas sevoflurane tended to drop pressure more substantially.11American Journal of Ophthalmology. The effects of sevoflurane and ketamine on intraocular pressure in children during examination under anesthesia For children being evaluated for conditions like glaucoma, this distinction matters a lot. A sedation agent that artificially lowers eye pressure could mask a dangerously high reading and delay treatment. Ketamine’s relative neutrality toward IOP is one reason it remains a preferred choice for pediatric eye examinations under sedation.
How Ketamine Alters Visual Perception
Beyond the mechanical behavior of the eyes themselves, ketamine changes the way the brain interprets what the eyes are seeing. In controlled studies with healthy volunteers, ketamine consistently induced a range of perceptual distortions but did not produce full-blown hallucinations.12PubMed Central. Psychological effects of ketamine in healthy volunteers. Phenomenological study People report that colors look different, objects seem to change shape or size, depth perception feels off, and the visual field can appear to shimmer or ripple. These are distortions of real visual input rather than the creation of things that are not there.
One specific and well-documented perceptual change involves contextual integration, the brain’s tendency to judge the brightness or contrast of an object based on its surroundings. Under normal conditions, a gray patch on a dark background looks brighter than the same gray patch on a light background. This is a visual illusion driven by the brain actively comparing context. Ketamine reduces this contextual integration effect. In a primate study measuring susceptibility to a standard brightness illusion, ketamine injection significantly decreased the illusion’s strength, meaning the animals judged contrast more veridically and were less influenced by the surrounding context.13Journal of Vision. N-methyl d-aspartate receptor hypofunction reduces visual contextual integration This is an unusual finding because it means ketamine is, in one narrow sense, making perception more accurate rather than less. However, contextual integration normally helps the visual system function in complex, real-world scenes, so losing it is not an advantage.
At the cortical level, ketamine amplifies high-frequency oscillatory activity in the visual cortex. A brain-imaging study using magnetoencephalography found that a standard subanesthetic dose significantly boosted gamma-band amplitudes in both motor and visual cortices while shifting the peak gamma frequency lower.14PubMed. Ketamine amplifies induced gamma frequency oscillations in the human cerebral cortex Gamma oscillations are associated with conscious visual processing, attention, and binding features of a visual scene together. The amplification is thought to result from the disinhibition of cortical pyramidal cells when NMDA receptors on inhibitory interneurons are blocked. In other words, ketamine removes a layer of braking in the cortex, and visual processing becomes louder and less regulated as a result. This may be part of the neural basis for the perceptual distortions that users report.
Retinal Effects
Ketamine’s influence reaches all the way back to the retina. When researchers compare how different anesthetics affect the electrical signals the retina generates in response to light, ketamine-based anesthesia stands out. In animal studies measuring electroretinograms, the ketamine group showed the largest electrical responses from both the rod-driven and cone-driven pathways. Specifically, the dark-adapted a- and b-waves, which reflect the activity of photoreceptors and inner retinal cells, were larger under ketamine than under other common anesthetics. The cone-driven b-wave was also the largest in the ketamine group.15PubMed Central. Effects of common anesthetics on eye movement and electroretinogram
This is a somewhat counterintuitive result. You might expect a sedating drug to dampen retinal responses, but ketamine appears to preserve or even enhance the retina’s ability to generate signals. The practical upshot is relevant for researchers who need to record accurate retinal responses from anesthetized animals or patients. Choosing ketamine over inhaled anesthetics like isoflurane may give cleaner, more robust retinal data, which is important for diagnosing retinal diseases or studying how the retina processes light.
Eye Signs in Forensic and Roadside Testing
Law enforcement officers trained in the Drug Evaluation and Classification (DEC) program use a battery of eye-related tests to identify impaired drivers and categorize the type of drug involved. Eye indicators turn out to be among the most powerful predictors of drug category. In an analysis of DEC evaluations, the condition of the eyes, eyelid state, horizontal gaze nystagmus assessment, convergence ability, pupil size in darkness, and reaction to light all contributed significantly to distinguishing which class of drug a person had taken.16PubMed. Predicting categories of drugs used by suspected drug-impaired drivers using the Drug Evaluation and Classification Program tests Eye-related indicators contributed more predictive power than clinical vital signs or physical coordination tests.
For ketamine specifically, roadside evaluations have identified a characteristic cluster of eye signs. Horizontal gaze nystagmus is the standout finding, often accompanied by a general appearance of altered consciousness and poor performance on divided-attention tests like walking heel-to-toe or standing on one leg.7PubMed. Roadside detection of impairment under the influence of ketamine–evaluation of ketamine impairment symptoms with reference to its concentration in oral fluid and urine The combination of visible nystagmus, sluggish pupil responses, and impaired coordination creates a recognizable profile, though it overlaps to some degree with the profiles produced by other dissociative anesthetics like PCP. Confirming the specific substance still requires toxicological testing, but the eye signs narrow the field considerably.
Dose Matters More Than You Might Think
One recurring theme across ketamine eye research is that different doses produce qualitatively different effects, not just milder or stronger versions of the same ones. At subanesthetic doses, the kind used in depression treatment or recreational settings, ketamine selectively disrupts predictive eye movements while leaving basic visual reflexes largely intact.2Psychopharmacology. A subanesthetic dose of ketamine in the Rhesus monkey reduces the occurrence of anticipatory saccades The animal is alert, behaving normally, but its brain is not planning its gaze as effectively. At moderate doses, smooth pursuit begins to break down, nystagmus appears, saccades get smaller and slower, and pupil responses become sluggish. At full anesthetic doses, the eye effects are more global and are mixed with the general depression of the nervous system, though the retina continues to produce robust electrical responses even then.
This dose dependency has practical implications for anyone receiving ketamine therapeutically. Patients getting a single low-dose infusion for treatment-resistant depression may notice mild visual disturbances and slightly off tracking of moving objects during the infusion, but these effects typically resolve within an hour or two as the drug clears. Clinics that administer ketamine for depression generally advise patients not to drive for the rest of the day, and the oculomotor impairments documented in research support that advice. Even when the subjective feeling of intoxication has passed, subtle deficits in eye movement control and smooth pursuit may linger slightly longer than the dissociative sensation itself.
Lingering Visual Disturbances After Use
A small fraction of people who use hallucinogenic or dissociative substances develop what is known as hallucinogen persisting perception disorder, or HPPD, in which visual disturbances such as halos, trailing images, geometric patterns, or afterimages recur well after the drug has left the body. While HPPD has been most associated with classic psychedelics like LSD, it can occur with other substances that produce visual distortions, and the broader category of dissociatives is not fully excluded from risk. Case reports exist, though the systematic data linking ketamine specifically to HPPD is thin compared to the literature on LSD or psilocybin.
What distinguishes HPPD from simple flashbacks is persistence and distress: the visual anomalies keep recurring over weeks or months and interfere with daily functioning. Most people who use ketamine, even repeatedly, never develop these symptoms. But anyone who notices unusual visual phenomena that persist well beyond the drug’s acute effects should be aware that the phenomenon exists and has a clinical name, which makes it easier to discuss with a healthcare provider. The visual disturbances themselves are thought to reflect lasting changes in the balance between excitatory and inhibitory signaling in visual processing areas, potentially related to the same NMDA receptor disruption that produces acute perceptual changes during ketamine use.
Why Psychiatry Cares About Ketamine Eyes
Eye movement abnormalities are among the most reliable biological markers in schizophrenia research. People with schizophrenia consistently show impaired smooth pursuit, increased saccadic intrusions during tracking, and altered antisaccade performance. The fact that ketamine, by blocking NMDA receptors, can reproduce many of these same eye movement deficits in healthy volunteers has made it a valuable research tool. Brain imaging during ketamine-impaired smooth pursuit reveals patterns of altered neural activity in oculomotor regions that resemble those seen in schizophrenia patients.6PubMed Central. Effects of ketamine on brain function during smooth pursuit eye movements
This line of research has helped establish that glutamate signaling through NMDA receptors plays a meaningful role in oculomotor control, and that disrupting this signaling produces a recognizable cluster of eye movement problems. For the general reader, the takeaway is that the eye effects of ketamine are not random side effects. They are windows into how a specific neurotransmitter system shapes visual behavior, and they have become one of the more productive ways researchers study the biology of psychosis without needing to study people who are actively ill.